한글목차

세계 합성생물학 시장 규모는 2023년 154억 달러, 2024년 193억 달러에서 예측 기간 동안 26.1%의 연평균 복합 성장률(CAGR)을 나타내고, 2029년 말에는 616억 달러 규모에 달할 것으로 예상됩니다.

인에이블드 제품 부문은 2024년 101억 달러에서 연평균 28.0% 성장하여 2029년 말에는 348억 달러에 이를 것으로 예상됩니다. 또한, 인에이블링 제품 부문은 2024년 68억 달러에서 연평균 25.1% 성장하여 2029년 말에는 210억 달러에 달할 것으로 예상됩니다.

세계 합성생물학(Synthetic Biology) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• 개요
• 밸류체인 분석
• 규제 프레임워크
• 미국 GEM 규제
• 합성생물학이 생물 다양성 보전에 미치는 영향
• 직접적인 영향
• 간접적인 영향

제3장 시장 역학

• 개요
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회

제4장 새로운 동향과 특허 분석

• 새로운 동향
• CRISPR-Cas 시스템
• 유전자 드라이브
• 확장 유전 코드
• 광유전체학
• 합성 유전체학
• 무세포 시스템
• 마이크로바이옴 공학
• 특허 분석
• 주요 부여 특허
• 특허 리뷰

제5장 시장 세분화 분석

• 세분화 내역
• 시장 분석 : 제품 유형별
• Enabled Products
• 구현 제품
• 생물학적 성분
• 통합 시스템
• 시장 분석 : 최종사용자별
• Enabled Products : 최종사용자별
• 구현 제품 최종사용자별
• 생물학적 성분 : 최종사용자별
• 통합 시스템 : 최종사용자별
• 지역 분석
• 시장 분석 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제6장 경쟁 정보

• 기업 점유율 분석
• 산업에 대한 투자

제7장 합성생물학 시장 지속가능성 : ESG 관점

• 개요
• 바이오테크놀러지 업계 ESG 동향
• ESG 리스크와 과제
• ESG 시점
• 환경에 대한 영향
• 사회적 영향
• 거버넌스와 윤리적 배려

제8장 부록

• 조사 방법
• 출전
• 두자어
• 기업 개요
• AGILENT TECHNOLOGIES INC.
• AMYRIS
• CODEXIS INC.
• EUROFINS SCIENTIFIC
• GENSCRIPT
• GINKGO BIOWORKS
• MERCK KGAA
• THERMO FISHER SCIENTIFIC INC.
• TWIST BIOSCIENCE
• VIRIDOS

영문목차

The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.

The global synthetic biology market for enabled products is projected to grow from $10.1 billion in 2024 to $34.8 billion by the end of 2029, at a CAGR of 28.0% from 2024 through 2029.

The global synthetic biology market for enabling products is projected to grow from $6.8 billion in 2024 to $21.0 billion by the end of 2029, at a CAGR of 25.1% from 2024 through 2029.

Report Scope:

The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2029.

Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2024 through 2029. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces is also provided.

BCC Research examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, and software. The market is also analyzed by end users, including agriculture, consumer products, cosmetics and skin care, food and beverage, healthcare, and industrial chemicals.

By geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Report Includes:

50 data tables and 45 additional tables

• An analysis of the global markets for synthetic biology products and technologies
• Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the current market size and revenue prospects, along with market share analysis by product type, end-user industry and region
• Facts and figures pertaining to the market drivers and challenges, innovations, technologies, industry regulations, and the influence of macroeconomic factors

Identification of core synthetic biology products, key enabling technologies, commercial opportunities for product development, and competitive strategies

• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, the ESG practices of leading companies and their ESG scores
• An analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene editing
• Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and venture funding outlook
• Profiles of the market leaders, including Ginkgo Bioworks, Amyris, Twist Bioscience, Codexis Inc., and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Value Chain Analysis
• Regulatory Framework
• Regulation of GEMs in the United States
• Impacts of Synthetic Biology on Biodiversity Conservation
• Direct Impacts
• Indirect Impacts

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Various Applications of Synthetic Biology in Diverse Fields
• Increasing Funding for Research and Development
• Declining Cost of DNA Sequencing
• Continuous Innovations in the Synthetic Biology Field
• Market Restraints
• Biosafety, Biosecurity, and Ethical Issues
• Market Opportunities
• Increasing Demand for Fuel Alternatives
• Use of Machine Learning in Synthetic Biology

Chapter 4 Emerging Trends and Patent Analysis

• Emerging Trends
• CRISPR-Cas Systems
• Gene Drives
• Expanded Genetic Code
• Optogenetics
• Synthetic Genomics
• Cell-Free System
• Microbiome Engineering
• Patent Analysis
• Select Patent Grants
• Patent Review

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis, by Product Type
• Enabled Products
• Enabling Products
• Biologic Components
• Integrated Systems
• Market Analysis, by End User
• Enabled Product, by End User
• Enabling Product, by End User
• Biologic Components, by End User
• Integrated Systems, by End User
• Geographic Breakdown
• Market Analysis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Company Share Analysis
• Investment in Industry

Chapter 7 Sustainability in Synthetic Biology Market: ESG Perspective

• Overview
• ESG Trends in the Biotechnology Industry
• ESG Risks and Challenges
• ESG Perspective
• Environmental Impact
• Social Impact
• Governance and Ethical Considerations

Chapter 8 Appendix

• Methodology
• Sources
• Acronyms
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• AMYRIS
• CODEXIS INC.
• EUROFINS SCIENTIFIC
• GENSCRIPT
• GINKGO BIOWORKS
• MERCK KGAA
• THERMO FISHER SCIENTIFIC INC.
• TWIST BIOSCIENCE
• VIRIDOS